AQ
Aequus Pharmaceuticals Inc.
AQSZF · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $130.3K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.14x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Rev. growth 40.07%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 56.95%
Net margin 71.46%
Op. margin 62.50%
Quality
79 /100
Excellent ROIC 22.38%
ROA 334.60%
Asset turnover 4.68x
Debt
0 /100
High Current ratio 0.03x
Int. coverage -1.99x
Debt/Equity N/A
Stability
23 /100
Unstable Beta -0.21x
Rev. volatility 113.49%
EPS volatility 52.84%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na AQSZF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Douglas Glen Janzen
Employees
12
Headquarters
Vancouver